2021 Q1 Form 10-Q Financial Statement
#000143774921012526 Filed on May 17, 2021
Income Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| Revenue | $19.46M | $16.43M |
| YoY Change | 18.45% | -17.74% |
| Cost Of Revenue | $12.34M | $11.27M |
| YoY Change | 9.56% | -36.41% |
| Gross Profit | $7.118M | $5.164M |
| YoY Change | 37.84% | 128.9% |
| Gross Profit Margin | 36.58% | 31.43% |
| Selling, General & Admin | $4.547M | $7.140M |
| YoY Change | -36.32% | 1.39% |
| % of Gross Profit | 63.88% | 138.26% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $99.00K | $9.000K |
| YoY Change | 1000.0% | -98.41% |
| % of Gross Profit | 1.39% | 0.17% |
| Operating Expenses | $4.547M | $7.140M |
| YoY Change | -36.32% | 1.39% |
| Operating Profit | $2.571M | -$1.976M |
| YoY Change | -230.11% | -58.71% |
| Interest Expense | $2.169M | $2.158M |
| YoY Change | 0.51% | -20.6% |
| % of Operating Profit | 84.36% | |
| Other Income/Expense, Net | -$2.188M | -$3.188M |
| YoY Change | -31.37% | -20.26% |
| Pretax Income | $383.0K | -$5.164M |
| YoY Change | -107.42% | -41.21% |
| Income Tax | $0.00 | |
| % Of Pretax Income | 0.0% | |
| Net Earnings | $383.0K | -$5.164M |
| YoY Change | -107.42% | -41.21% |
| Net Earnings / Revenue | 1.97% | -31.43% |
| Basic Earnings Per Share | $0.00 | -$0.02 |
| Diluted Earnings Per Share | $0.00 | -$0.02 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 258.1M shares | 256.8M |
| Diluted Shares Outstanding | 259.1M shares | 256.8M |
Balance Sheet
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $3.236M | $478.0K |
| YoY Change | 576.99% | -71.41% |
| Cash & Equivalents | $3.236M | $478.0K |
| Short-Term Investments | ||
| Other Short-Term Assets | $2.838M | $3.404M |
| YoY Change | -16.63% | -49.59% |
| Inventory | $9.411M | $7.230M |
| Prepaid Expenses | $2.838M | $3.404M |
| Receivables | $9.794M | $8.043M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $25.28M | $19.16M |
| YoY Change | 31.97% | -29.15% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $60.00K | $82.00K |
| YoY Change | -26.83% | -91.17% |
| Goodwill | $8.818M | $8.818M |
| YoY Change | 0.0% | -50.45% |
| Intangibles | $3.159M | $4.085M |
| YoY Change | -22.67% | -80.48% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $744.0K | $815.0K |
| YoY Change | -8.71% | -52.12% |
| Total Long-Term Assets | $18.19M | $19.11M |
| YoY Change | -4.83% | -53.79% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $25.28M | $19.16M |
| Total Long-Term Assets | $18.19M | $19.11M |
| Total Assets | $43.47M | $38.27M |
| YoY Change | 13.59% | -44.05% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $7.299M | $4.579M |
| YoY Change | 59.4% | -52.75% |
| Accrued Expenses | $26.66M | $19.64M |
| YoY Change | 35.74% | 21.99% |
| Deferred Revenue | $4.955M | |
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $100.1M | $94.58M |
| YoY Change | 5.82% | 28.92% |
| Total Short-Term Liabilities | $139.0M | $123.2M |
| YoY Change | 12.78% | 18.35% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $1.026M | $0.00 |
| YoY Change | -100.0% | |
| Other Long-Term Liabilities | $5.217M | $5.117M |
| YoY Change | 1.95% | 294.53% |
| Total Long-Term Liabilities | $6.243M | $5.117M |
| YoY Change | 22.01% | -68.6% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $139.0M | $123.2M |
| Total Long-Term Liabilities | $6.243M | $5.117M |
| Total Liabilities | $145.2M | $128.4M |
| YoY Change | 13.14% | 6.58% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$332.9M | -$321.2M |
| YoY Change | 3.63% | 13.44% |
| Common Stock | $394.0K | $392.0K |
| YoY Change | 0.51% | 0.51% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $500.0K | $500.0K |
| YoY Change | 0.0% | 0.0% |
| Treasury Stock Shares | $134.8M | $134.8M |
| Shareholders Equity | -$101.8M | -$92.92M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $43.47M | $38.27M |
| YoY Change | 13.59% | -44.05% |
Cashflow Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $383.0K | -$5.164M |
| YoY Change | -107.42% | -41.21% |
| Depreciation, Depletion And Amortization | $99.00K | $9.000K |
| YoY Change | 1000.0% | -98.41% |
| Cash From Operating Activities | -$757.0K | -$2.933M |
| YoY Change | -74.19% | -54.7% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $0.00 | |
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | ||
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $3.569M | 3.141M |
| YoY Change | 13.63% | 63.59% |
| NET CHANGE | ||
| Cash From Operating Activities | -$757.0K | -2.933M |
| Cash From Investing Activities | ||
| Cash From Financing Activities | $3.569M | 3.141M |
| Net Change In Cash | 2.812M | 208.0K |
| YoY Change | 1251.92% | -104.57% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$757.0K | -$2.933M |
| Capital Expenditures | $0.00 | |
| Free Cash Flow | -$757.0K | |
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
| CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
| CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001590695 | |
| CY2021Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
259092833 | |
| CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Twinlab Consolidated Holdings, Inc. | |
| CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2021Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value per share | |
| CY2021Q1 | dei |
Trading Symbol
TradingSymbol
|
tlcc | |
| CY2021Q1 | tlcc |
Allowance For Accounts Receivable Current Doubtful Accounts
AllowanceForAccountsReceivableCurrentDoubtfulAccounts
|
1544000 | |
| CY2020Q4 | tlcc |
Allowance For Accounts Receivable Current Doubtful Accounts
AllowanceForAccountsReceivableCurrentDoubtfulAccounts
|
1127000 | |
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Canceled During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCanceledDuringPeriodExercisePriceOfWarrantsOrRights
|
||
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Cancelled During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
|
||
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Exercised During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodExercisePriceOfWarrantsOrRights
|
||
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
|
1034702 | |
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Granted During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodExercisePriceOfWarrantsOrRights
|
||
| CY2021Q1 | tlcc |
Class Of Warrant Or Right Granted During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
|
||
| CY2021Q1 | tlcc |
Contract With Customer Customer Deposits Current
ContractWithCustomerCustomerDepositsCurrent
|
4895000 | |
| CY2020Q4 | tlcc |
Contract With Customer Customer Deposits Current
ContractWithCustomerCustomerDepositsCurrent
|
3874000 | |
| CY2021Q1 | tlcc |
Depreciation Depletion And Amortization Excluding Amortization Of Right Of Use Assets
DepreciationDepletionAndAmortizationExcludingAmortizationOfRightOfUseAssets
|
99000 | |
| CY2020Q1 | tlcc |
Depreciation Depletion And Amortization Excluding Amortization Of Right Of Use Assets
DepreciationDepletionAndAmortizationExcludingAmortizationOfRightOfUseAssets
|
267000 | |
| CY2021Q1 | tlcc |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-217000 | |
| CY2020Q1 | tlcc |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-192000 | |
| CY2021Q1 | tlcc |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
1356000 | |
| CY2020Q1 | tlcc |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
||
| CY2021Q1 | tlcc |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
||
| CY2021Q1 | tlcc |
Subscription Receivable Annual Interest Rate
SubscriptionReceivableAnnualInterestRate
|
0.05 | |
| CY2021Q1 | tlcc |
Working Capital Deficiency
WorkingCapitalDeficiency
|
113712000 | |
| CY2021Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
8844000 | |
| CY2020Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
9372000 | |
| CY2021Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
7299000 | |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4712000 | |
| CY2021Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
9794000 | |
| CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8425000 | |
| CY2021Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
231249000 | |
| CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
231250000 | |
| CY2021Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2642000 | |
| CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2101000 | |
| CY2021Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
215000 | |
| CY2020Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
305000 | |
| CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
94000 | |
| CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
278000 | |
| CY2021Q1 | us-gaap |
Assets
Assets
|
43468000 | |
| CY2020Q4 | us-gaap |
Assets
Assets
|
34951000 | |
| CY2021Q1 | us-gaap |
Assets Current
AssetsCurrent
|
25279000 | |
| CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
17345000 | |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3236000 | |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
424000 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
424000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
270000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3236000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
478000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
2812000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
208000 | |
| CY2020Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.07 | |
| CY2021Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.09 | |
| CY2020Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
6034702 | |
| CY2021Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
5000000 | |
| CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2021Q1 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
30000 | |
| CY2020Q4 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
30000 | |
| CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | |
| CY2021Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
393898884 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
392864182 | |
| CY2021Q1 | us-gaap |
Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
|
1528384 | |
| CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
394000 | |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
393000 | |
| CY2021Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Significant Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Sales to our top <div style="display: inline; font-style: italic; font: inherit;">three</div> customers aggregated to approximately <div style="display: inline; font-style: italic; font: inherit;">28%</div> and <div style="display: inline; font-style: italic; font: inherit;">33%</div> of total sales for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;">2020,</div> respectively. Sales to <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">one</div></div> of those customers were approximately <div style="display: inline; font-style: italic; font: inherit;">8%</div> and <div style="display: inline; font-style: italic; font: inherit;">17%</div> of total sales for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;">2020,</div> respectively. Accounts receivable from the top <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">three</div></div></div> customers were approximately <div style="display: inline; font-style: italic; font: inherit;">43%</div> and <div style="display: inline; font-style: italic; font: inherit;">21%</div> of total accounts receivable as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>respectively. A <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">single</div></div> customer represents <div style="display: inline; font-style: italic; font: inherit;">4%</div> and <div style="display: inline; font-style: italic; font: inherit;">10%</div> of total accounts receivable as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>respectively, and this customer is a related party through a director who sits on both the Company's board and that of the customer.</div></div></div> | |
| CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
4955000 | |
| CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
3934000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
|
60000 | |
| CY2020Q4 | us-gaap |
Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
|
60000 | |
| CY2021Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
12342000 | |
| CY2020Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
11265000 | |
| CY2021Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
||
| CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
10363000 | |
| CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
10269000 | |
| CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3658000 | |
| CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6857000 | |
| CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
8818000 | |
| CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
8818000 | |
| CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
7118000 | |
| CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
5164000 | |
| CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
383000 | |
| CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5164000 | |
| CY2020Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-1030000 | |
| CY2021Q1 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
||
| CY2020Q1 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
||
| CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
||
| CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
||
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
| CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2588000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1734000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1910000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2967000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1073000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
2157000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2593000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
843000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-14000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-18000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
643000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
285000 | |
| CY2021Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
1028430 | |
| CY2020Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
||
| CY2021Q1 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
1400000 | |
| CY2020Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
1400000 | |
| CY2021Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
13522000 | |
| CY2020Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
13522000 | |
| CY2021Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3159000 | |
| CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3253000 | |
| CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
2169000 | |
| CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
2158000 | |
| CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
354000 | |
| CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
139000 | |
| CY2021Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
21959000 | |
| CY2020Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
20359000 | |
| CY2021Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
5694000 | |
| CY2020Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
5994000 | |
| CY2021Q1 | us-gaap |
Inventory Gross
InventoryGross
|
10640000 | |
| CY2020Q4 | us-gaap |
Inventory Gross
InventoryGross
|
8047000 | |
| CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
9411000 | |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
6301000 | |
| CY2021Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4946000 | |
| CY2020Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2053000 | |
| CY2021Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
1229000 | |
| CY2020Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
1746000 | |
| CY2021Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
-517000 | |
| CY2020Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
180000 | |
| CY2021Q1 | us-gaap |
Lease Cost
LeaseCost
|
199000 | |
| CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
198000 | |
| CY2021Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
6243000 | |
| CY2020Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
5068000 | |
| CY2021Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
1026000 | |
| CY2020Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
476000 | |
| CY2021Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
100081000 | |
| CY2020Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
96847000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
7563000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1265000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1369000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1333000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
1298000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
942000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
1538000 | |
| CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
145234000 | |
| CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
137100000 | |
| CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
43468000 | |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
34951000 | |
| CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
138991000 | |
| CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
132032000 | |
| CY2021Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
101107000 | |
| CY2020Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
97323000 | |
| CY2021Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
100081000 | |
| CY2020Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
96847000 | |
| CY2021Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1026000 | |
| CY2020Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
476000 | |
| CY2021Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1</div> </div>–<div style="display: inline; font-weight: bold;"> Nature of Business </div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Nature of Business</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Twinlab Consolidated Holdings, Inc. (the “Company”, “Twinlab,” “we,” “our” and “us”) was incorporated on <div style="display: inline; font-style: italic; font: inherit;"> October 24, 2013 </div>under the laws of the State of Nevada as Mirror Me, Inc. On <div style="display: inline; font-style: italic; font: inherit;"> August 7, 2014, </div>we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">We are an integrated marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Our products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab brand name, a market leader in the healthy aging and beauty from within categories sold under the Reserveage Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife brand name; the Re-Body brand name; and a full line of herbal teas sold under the Alvita brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers. </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">We also perform contract manufacturing services for private label products through NutraScience Labs. Our contract manufacturing services business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer's own brand name. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> market these private label products as our business is to sell the products to the customer, who then markets and sells the products to retailers or end consumers.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Going Concern</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>we had an accumulated deficit of <div style="display: inline; font-style: italic; font: inherit;">$332,879.</div> Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing. Losses have been funded primarily through debt.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Because of our history of operating losses and significant interest expense on our debt we have a working capital deficiency of <div style="display: inline; font-style: italic; font: inherit;">$113,712</div> as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021. </div>We also have <div style="display: inline; font-style: italic; font: inherit;">$100,081</div> of debt, net of discount, presented in current liabilities. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">Management has addressed operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing operating costs that include significant workforce and salary expense reduction and continuing to negotiate lower prices from major suppliers. We believe that we <div style="display: inline; font-style: italic; font: inherit;"> may </div>need additional capital to execute our business plan. If additional funding is required, there can be <div style="display: inline; font-style: italic; font: inherit;">no</div> assurance that sources of funding will be available when needed on acceptable terms or at all. To meet capital requirements, the Company <div style="display: inline; font-style: italic; font: inherit;"> may </div>consider selling certain assets or seeking financing through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing agreements.</div></div> | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3569000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3141000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-757000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2933000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
383000 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5164000 | |
| CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
383000 | |
| CY2020Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-5164000 | |
| CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5408000 | |
| CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4710000 | |
| CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
210000 | |
| CY2020Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
193000 | |
| CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2188000 | |
| CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3188000 | |
| CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
2571000 | |
| CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1976000 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
6025000 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
808000 | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
742000 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
5217000 | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4592000 | |
| CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
323000 | |
| CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
315000 | |
| CY2021Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0825 | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0825 | |
| CY2021Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y292D | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y292D | |
| CY2021Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
744000 | |
| CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
760000 | |
| CY2021Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
||
| CY2020Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-5000 | |
| CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-19000 | |
| CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
||
| CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
500000000 | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
500000000 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2021Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2021Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2838000 | |
| CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2195000 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
1344000 | |
| CY2020Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
5000000 | |
| CY2021Q1 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
2225000 | |
| CY2020Q1 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
453000 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102149000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-87760000 | |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-92924000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
60000 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
65000 | |
| CY2021Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
541000 | |
| CY2020Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
4097000 | |
| CY2021Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
||
| CY2020Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
2312000 | |
| CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-332879000 | |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-333262000 | |
| CY2021Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
19460000 | |
| CY2020Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
16429000 | |
| CY2021Q1 | us-gaap |
Revenues
Revenues
|
19460000 | |
| CY2020Q1 | us-gaap |
Revenues
Revenues
|
16429000 | |
| CY2021Q1 | us-gaap |
Selling Expense
SellingExpense
|
889000 | |
| CY2020Q1 | us-gaap |
Selling Expense
SellingExpense
|
283000 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
7194412 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-101766000 | |
| CY2021Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
193000 | |
| CY2020Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
188000 | |
| CY2021Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
134806051 | |
| CY2020Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
134806051 | |
| CY2021Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
500000 | |
| CY2020Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
500000 | |
| CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.</div></div></div> | |
| CY2021Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
81000 | |
| CY2020Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
70000 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
259086561 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
256785233 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
258058131 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
256785233 |
